UnknownNot Applicable

RECO in the Endovascular Treatment of Acute Ischemic Stroke

China1,000 participantsStarted 2020-05-22

Plain-language summary

Investigate Reco ® ,the first clot retriever in china as the primary therapyand remedies in the real world.

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Age ≥ 18 years old
✓. Diagnosis of acute ischemic stroke
✓. Imaging confirmed intracranial large artery occlusion (LVO): intracranial internal carotid artery (ICA T/L), middle cerebral artery (MCA M1/M2), anterior cerebral artery (ACA A1/A2), basilar artery (BA), vertebral artery (VA V4), and posterior cerebral artery (PCA P1);ASPECT or PC-ASPECT ≥ 6
✓. Initiation of any type of endovascular treatment (EVT), including intra-arterial thrombolysis, mechanical thrombectomy, angioplasty, and stenting
✓. The patient or the patient's legal representative is able and willing to sign the informed consent

Functional independence at 90 days (modified Rankin Scale of 0-2)

Timeframe: [90±7 days after procedure]

Symptomatic intracranial hemorrhage (sICH) within 12-36 hours after the procedure

Timeframe: 12-36 hours after the procedure

Time from symptom onset to recanalization

Timeframe: From the time of symptom onset until the time of of the recanalization of the occluded artery, assessed up to 48 hours

NCT IDNCT04840719

SponsorBeijing Tiantan Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-31

Baixue Jia, PhD,MD